Does zinc deficiency impair immune regulation, tissue repair, antioxidant defense, and inflammatory resolution?

Zinc status is a critical determinant of immunological, structural, and redox homeostasis. In aging physiology, suboptimal zinc levels accelerate "inflammaging" and delay tissue recovery.

Molecular and cellular mechanisms

• Immune deregulation: Zinc deficiency inactivates thymulin, a zinc-dependent nonapeptide hormone, which arrests T-cell maturation, causes thymic atrophy, and skews helper T-cells toward inflammatory cytokine profiles.
• Impaired inflammatory resolution: Insufficient zinc blunts the expression of the zinc-finger protein A20 (TNFAIP3). This disables critical negative feedback on the NF-κB pathway, leading to sustained NF-κB nuclear translocation. Consequently, macrophages are trapped in a pro-inflammatory M1-like state, preventing the transition to tissue-repairing M2-like phenotypes.
• Weakened antioxidant defense: Inadequate zinc destabilizes cytosolic superoxide dismutase (Cu/Zn-SOD1), downregulates Nrf2-mediated transcription of antioxidant genes, and reduces metallothionein expression. This induces a pro-oxidant state characterized by elevated lipid peroxidation (malondialdehyde) and DNA oxidation markers (8-hydroxy-2'-deoxyguanosine).

Tissue repair and clinical implications

• Delayed wound healing: Zinc deficiency directly compromises fibroblast proliferation, downregulates collagen gene transcription (COL1A1 and COL3A1), delays epithelialization, and impairs zinc-dependent matrix metalloproteinase (MMP) remodeling activity.
• Systemic inflammation: Low serum zinc levels correlate with elevations in high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6). Clinical evidence indicates that physiological zinc supplementation (20 to 45 mg/day) effectively restores thymulin activity, lowers hs-CRP and IL-6, and reverses biomarkers of oxidative stress.

Bottom line

• Zinc deficiency directly impairs immune regulation, tissue repair, antioxidant capacity, and inflammatory resolution through interconnected molecular pathways—specifically by inactivating thymulin, destabilizing Cu/Zn-SOD1, and disinhibiting NF-κB via A20 downregulation. Correcting these deficits with 20 to 45 mg/day of oral zinc helps mitigate chronic systemic inflammation and delayed healing, presenting a crucial therapeutic consideration for older adults.